P
Paradigm
A company that is rebuilding the clinical research ecosystem by creating a platform that enables equitable access to trials for all patients
About Paradigm
Paradigm Inc. is a pioneering startup that is revolutionizing the healthcare industry by creating a more efficient ecosystem for patient care. The company's primary focus is to reduce the burden on physicians, thereby increasing patient access and speeding up study timelines. This innovative approach aims to provide equitable access to the best possible care for patients, regardless of their location.
Read full description
The company operates in the healthcare and drug development market, serving a broad range of clients including healthcare providers, research institutions, and patients. The business model of Paradigm Inc. is built around the development and operation of a platform that streamlines healthcare processes. The company generates revenue by offering its platform as a service to healthcare providers and research institutions.
The leadership team of Paradigm Inc. comprises industry veterans with extensive experience in healthcare, drug development, and technology. The team includes former executives from Merck, Regeneron, and the U.S. Food & Drug Administration, among others. The company is backed by leading investment funds, including ARCH Venture Partners and General Catalyst, indicating strong financial support and confidence in its vision.
In summary, Paradigm Inc. is a promising startup with a unique approach to healthcare and drug development. Its platform aims to improve patient care by reducing physician burden and accelerating study timelines. With a strong leadership team and backing from leading investment funds, the company is well-positioned to disrupt the healthcare industry.
At a glance
- Status
- Operational
- Founded
- 2022
- Headquarters
- Columbus, United States
- Employees
- 201
- Open positions
- None listed
- Dealroom signal
- 92.1/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Rumoured $1B, Hard Tech
- Client focus
- b2b
- Investment activity
- 2 companies, latest Mar 2025
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Dec 2025 | $78M | $1B | Lux Capital · General Catalyst · GV · DFJ Growth | ↗ |
| SERIES AOther financing | Jan 2023 | $203M | $812M | GV · BrightEdge · Magnetic Ventures · General Catalyst | ↗ |
Growth signals
Latest recorded traffic for Paradigm is 11K monthly website visits, up 44.7% over the last three months. Paradigm's team grew 9.2% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
AcrossChicago, United StatesA fast, cost-efficient and secure bridge where you can instantly send assets between L2s and Ethereum
$200Mvaluation
Deep LensColumbus, United StatesSaas-based precision medicine software suite
$56Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A9 investors entered at this stage
General Catalyst
ARCH Venture Partners
GV
BrightEdge
Magnetic Ventures
Lux Capital
F-Prime
Mubadala Capital
DFJ Growth
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Paradigm on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Paradigm’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.